These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 16806604

  • 1. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
    Chackerian B, Rangel M, Hunter Z, Peabody DS.
    Vaccine; 2006 Sep 11; 24(37-39):6321-31. PubMed ID: 16806604
    [Abstract] [Full Text] [Related]

  • 2. Vaccination with Abeta-displaying virus-like particles reduces soluble and insoluble cerebral Abeta and lowers plaque burden in APP transgenic mice.
    Bach P, Tschäpe JA, Kopietz F, Braun G, Baade JK, Wiederhold KH, Staufenbiel M, Prinz M, Deller T, Kalinke U, Buchholz CJ, Müller UC.
    J Immunol; 2009 Jun 15; 182(12):7613-24. PubMed ID: 19494285
    [Abstract] [Full Text] [Related]

  • 3. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
    Rossi M, Piovesan P, Ghirardi O, Mastroianni D, Bombardi V, Battistini L, Cencioni MT, Capobianco D, Borsini F, Colombo M, Verdoliva A.
    Mol Immunol; 2009 Aug 15; 46(13):2524-32. PubMed ID: 19535144
    [Abstract] [Full Text] [Related]

  • 4. Virus-like particle based vaccines for Alzheimer disease.
    Chackerian B.
    Hum Vaccin; 2010 Nov 15; 6(11):926-30. PubMed ID: 20864801
    [Abstract] [Full Text] [Related]

  • 5. Reduced oligomeric and vascular amyloid-beta following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine.
    DaSilva KA, Brown ME, McLaurin J.
    Vaccine; 2009 Feb 25; 27(9):1365-76. PubMed ID: 19150380
    [Abstract] [Full Text] [Related]

  • 6. HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele.
    Zota V, Nemirovsky A, Baron R, Fisher Y, Selkoe DJ, Altmann DM, Weiner HL, Monsonego A.
    J Immunol; 2009 Sep 01; 183(5):3522-30. PubMed ID: 19675171
    [Abstract] [Full Text] [Related]

  • 7. Mutant amyloid-beta-sensitized dendritic cells as Alzheimer's disease vaccine.
    Cao C, Lin X, Zhang C, Wahi MM, Wefes I, Arendash G, Potter H.
    J Neuroimmunol; 2008 Aug 30; 200(1-2):1-10. PubMed ID: 18649951
    [Abstract] [Full Text] [Related]

  • 8. Specific humoral immune responses in rhesus monkeys vaccinated with the Alzheimer's disease-associated beta-amyloid 1-15 peptide vaccine.
    Li SB, Wang HQ, Lin X, Xu J, Xie Y, Yuan QF, Yao ZB.
    Chin Med J (Engl); 2005 Apr 20; 118(8):660-4. PubMed ID: 15899121
    [Abstract] [Full Text] [Related]

  • 9. Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: toward safer and effective vaccines against Alzheimer's disease.
    Kim HD, Maxwell JA, Kong FK, Tang DC, Fukuchi K.
    Biochem Biophys Res Commun; 2005 Oct 14; 336(1):84-92. PubMed ID: 16126169
    [Abstract] [Full Text] [Related]

  • 10. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
    Bard F, Barbour R, Cannon C, Carretto R, Fox M, Games D, Guido T, Hoenow K, Hu K, Johnson-Wood K, Khan K, Kholodenko D, Lee C, Lee M, Motter R, Nguyen M, Reed A, Schenk D, Tang P, Vasquez N, Seubert P, Yednock T.
    Proc Natl Acad Sci U S A; 2003 Feb 18; 100(4):2023-8. PubMed ID: 12566568
    [Abstract] [Full Text] [Related]

  • 11. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
    Bessa J, Schmitz N, Hinton HJ, Schwarz K, Jegerlehner A, Bachmann MF.
    Eur J Immunol; 2008 Jan 18; 38(1):114-26. PubMed ID: 18081037
    [Abstract] [Full Text] [Related]

  • 12. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
    Nemirovsky A, Fisher Y, Baron R, Cohen IR, Monsonego A.
    Vaccine; 2011 May 23; 29(23):4043-50. PubMed ID: 21473952
    [Abstract] [Full Text] [Related]

  • 13. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
    Zou J, Yao Z, Zhang G, Wang H, Xu J, Yew DT, Forster EL.
    J Neurol Sci; 2008 Sep 15; 272(1-2):87-98. PubMed ID: 18571202
    [Abstract] [Full Text] [Related]

  • 14. Differences in the immune response to long term Abeta vaccination in C57BL/6 and B6D2F1 mice.
    Seabrook TJ, Iglesias M, Bloom JK, Spooner ET, Lemere CA.
    Vaccine; 2004 Sep 28; 22(29-30):4075-83. PubMed ID: 15364459
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.
    Muhs A, Hickman DT, Pihlgren M, Chuard N, Giriens V, Meerschman C, van der Auwera I, van Leuven F, Sugawara M, Weingertner MC, Bechinger B, Greferath R, Kolonko N, Nagel-Steger L, Riesner D, Brady RO, Pfeifer A, Nicolau C.
    Proc Natl Acad Sci U S A; 2007 Jun 05; 104(23):9810-5. PubMed ID: 17517595
    [Abstract] [Full Text] [Related]

  • 20. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
    Solomon B.
    Curr Opin Mol Ther; 2007 Feb 05; 9(1):79-85. PubMed ID: 17330405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.